How much funding has Leal Health (fka TrialJectory) raised?

Leal Health (fka TrialJectory) has raised $27.0M in total funding, most recently a Series B round.

When was Leal Health (fka TrialJectory) founded?

Leal Health (fka TrialJectory) was founded in 2019.

Where is Leal Health (fka TrialJectory) headquartered?

Leal Health (fka TrialJectory) is headquartered in Closter, New Jersey, United States.

What industry is Leal Health (fka TrialJectory) in?

Leal Health (fka TrialJectory) operates in Artificial Intelligence, Healthcare.

How many employees does Leal Health (fka TrialJectory) have?

Leal Health (fka TrialJectory) has 11-50 employees.

Leal Health (fka TrialJectory)

Q: Who are Leal Health (fka TrialJectory)'s investors?

Leal Health (fka TrialJectory)'s investors include Contour Venture Partners, Insight Partners, Existing investors, JAL Ventures.

Acquired

Treatments. Choices. Hope.

Closter, United States · Founded 2019 · $27.0M raised

Artificial Intelligence

Healthcare

Headquarters: Closter, New Jersey
Employees: 11–50
Founded: 2019
Business Model: B2B2C

Website: trialjectory.com
Total Funding: $27.0M
Last Round: $4.2M Series BDec 2023
Rounds: 3

About

Leal Health (formerly TrialJectory) is a patient-first AI platform dedicated to democratizing access to advanced cancer treatment. Its AI-powered decision-support platform matches patients to clinical trials and cutting-edge cancer treatments based on self-reported clinical information, providing a personalized list of options in minutes. The platform serves patients, oncologists, and biopharma companies, and has facilitated over 5 million treatment matches. Recognized by TIME as one of the Best Inventions of 2020, Leal partners with leading cancer advocacy organizations to ensure unbiased access. In February 2026, Leal Health was acquired by Nexus Precision Health.

Summary

Leal Health (fka TrialJectory) is an Artificial Intelligence company based in Closter, United States, founded in 2019. It has raised $27.0M in total across 3 rounds, most recently a $4.2M Series B round in Dec 2023. Investors include Contour Venture Partners, Insight Partners and Existing investors.